Related Experiment Video
Updated: Oct 16, 2025
11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
7.8K
Osteogenesis Imperfecta: Current and Prospective Therapies
Malwina Botor1, Agnieszka Fus-Kujawa1, Marta Uroczynska1
1Department of Molecular Biology and Genetics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland.
Biomolecules
|October 23, 2021
Summary
Osteogenesis Imperfecta (OI) is a brittle bone disease affecting 1:15,000 births. Current treatments have limitations, but stem cell and genetic therapies show promise for improved OI management.
Area of Science:
- Genetics
- Biochemistry
- Pediatrics
Background:
- Osteogenesis Imperfecta (OI) encompasses connective tissue disorders marked by significant bone fragility.
- Prevalence is estimated between 1:15,000 to 1:20,000 births, with five main types (I-V) exhibiting varying severity.
- OI is primarily caused by mutations affecting type I collagen (col I) synthesis or processing, impacting osteoblast differentiation.
Purpose of the Study:
- To review the current understanding of Osteogenesis Imperfecta.
- To summarize existing therapeutic strategies and their limitations.
- To explore emerging experimental treatments for OI.
Main Methods:
- Literature review of Osteogenesis Imperfecta (OI) phenotypes, genetics, and current treatments.
- Analysis of the efficacy and limitations of bisphosphonates, Denosumab, parathyroid hormone, and growth hormone therapies.
- Evaluation of experimental approaches including stem cell transplantation and genetic engineering.
Main Results:
- OI presents a spectrum of phenotypes, from mild to lethal, linked to collagen gene mutations.
- Current treatments like bisphosphonates offer limited effectiveness and potential side effects.
- Stem cell transplantation and genetic engineering are emerging as promising therapeutic avenues for OI.
Conclusions:
- Osteogenesis Imperfecta is a complex genetic disorder with diverse clinical manifestations.
- Existing treatments for OI have notable drawbacks in efficacy and safety.
- Novel therapeutic strategies like stem cell and gene therapies hold significant potential for advancing OI treatment.
More Related Videos
Related Concept Videos
01:27Fractures: Bone Repair
4.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.0K
01:22Bone Marrow Sampling and Transplants
563
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
563
01:29Bone Disorders
4.2K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.2K
01:31Osteoclasts in Bone Remodeling
3.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K